Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pirfenidone Reduces Epithelial–Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs)
Hamidreza Aboulkheyr Es, Thomas R. Cox, Ehsan Sarafraz-Yazdi, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5118-5118
Open Access | Times Cited: 23

Showing 23 citing articles:

The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies
Jiayun Wei, Jia Yao, Mengchao Yan, et al.
Acta Biomaterialia (2022) Vol. 150, pp. 34-47
Open Access | Times Cited: 34
Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment
Kris Raaijmakers, Gosse J. Adema, Johan Bussink, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
An overview of extracellular matrix and its remodeling in the development of cancer and metastasis with a glance at therapeutic approaches
Kimiya Afshar, Mohammad‐Javad Sanaei, Mehrnaz Sadat Ravari, et al.
Cell Biochemistry and Function (2023) Vol. 41, Iss. 8, pp. 930-952
Open Access | Times Cited: 12
Despicable role of epithelial–mesenchymal transition in breast cancer metastasis: Exhibiting de novo restorative regimens
Paras Famta, Saurabh Shah, Biswajit Dey, et al.
Cancer Pathogenesis and Therapy (2024) Vol. 3, Iss. 1, pp. 30-47
Open Access | Times Cited: 4
Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis
Linghui Zou, Peng Xian, Qing Pu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
The role of matrix stiffness in breast cancer progression: a review
Ruoxi Xu, Yin Peng, Ji‐Fu Wei, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Targeting Cancer-Associated Fibroblasts with Pirfenidone: A Novel Approach for Cancer Therapy
Nima Rastegar‐Pouyani, Mohadeseh Haji Abdolvahab, Mohammad Amin Farzin, et al.
Tissue and Cell (2024) Vol. 91, pp. 102624-102624
Closed Access | Times Cited: 3
Decellularized plant-derived vasculature-on-a-chip interacting with breast cancer spheroids to evaluate a dual-drug therapy
Yagmur Filiz, Yagmur Arslan, Elif Duran, et al.
Applied Materials Today (2023) Vol. 36, pp. 102015-102015
Closed Access | Times Cited: 7
Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models
Maria L. Lotsberg, Gro Vatne Røsland, Austin Rayford, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Cancer-Associated Fibroblasts in a 3D Engineered Tissue Model Induce Tumor-like Matrix Stiffening and EMT Transition
Martial Millet, Enola Bollmann, Cassandra Ringuette Goulet, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3810-3810
Open Access | Times Cited: 12
Pirfenidone promotes the levels of exosomal miR-200 to down-regulate ZEB1 and represses the epithelial-mesenchymal transition of non-small cell lung cancer cells
Jingjing Liu, Liming Cao, Yuanyuan Li, et al.
Human Cell (2022) Vol. 35, Iss. 6, pp. 1813-1823
Closed Access | Times Cited: 12
Targets in the Tumour Matrisome to Promote Cancer Therapy Response
Siti Munira Abd Jalil, Jack C. Henry, Angus J.M. Cameron
Cancers (2024) Vol. 16, Iss. 10, pp. 1847-1847
Open Access | Times Cited: 2
Breast tumor-on-chip: from the tumor microenvironment to medical applications
Yiying Liu, Ruonan Liu, He Liu, et al.
The Analyst (2023) Vol. 148, Iss. 23, pp. 5822-5842
Closed Access | Times Cited: 4
Pirfenidone inhibits TGF‐β1‐induced metabolic reprogramming during epithelial‐mesenchymal transition in non‐small cell lung cancer
Shuling Zhang, Yuanmei Wang, Daiqin Luo, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 3
Open Access | Times Cited: 4
Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies
Huiguang Chen, Xuexin Xu, Jingxian Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies
Daniel Pouliquen, Alice Boissard, Cécile Henry, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Interaction between tumor microenvironment, autophagy, and epithelial-mesenchymal transition in tumor progression
Wen‐Ming Wang, Hua Shen, Zi‐Ning Liu, et al.
Cancer Treatment and Research Communications (2022) Vol. 32, pp. 100592-100592
Open Access | Times Cited: 4
Pirfenidone promotes cell cycle arrest and apoptosis of triple‑negative breast cancer cells by suppressing Hedgehog/GLI1 signaling
Shengyu Shi, Lingyu Zhao, C.F. Liu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Preclinical studies on the antitumor and non‐toxic effect of combining pirfenidone with vinorelbine and carboplatin in non‐small cell lung cancer
Helena Branco, Catarina A. Rodrigues, Júlio Oliveira, et al.
International Journal of Cancer (2024)
Open Access
Avaliação de quimiocinas circulantes em pacientes com câncer de mama, o ardiloso luminal b e as misteriosas quimiocinas
Rogério Araújo
(2023)
Open Access
Stemness Landscape and Its Clinical Implications in Hepatocellular Carcinoma
Xuankun Gong, Ling Bao, Yuanrong Chen, et al.
Research Square (Research Square) (2023)
Open Access
miRNAs Delivery for Cancer-associated Fibroblasts’ Activation and Drug Resistance in Cancer Microenvironment
Sara Anajafi, Mahdi Paryan, Amineh Khoshnazar, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 24, Iss. 3, pp. 333-347
Closed Access
Development and Validation of an Individualized Immune Prognostic Signature in HNSCC
Jintao Yu, Xia Sun, Yichen Zhao, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top